chr16-4990885-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014692.2(SEC14L5):āc.464A>Gā(p.Asn155Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,599,556 control chromosomes in the GnomAD database, with no homozygous occurrence. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEC14L5 | NM_014692.2 | c.464A>G | p.Asn155Ser | missense_variant | 5/16 | ENST00000251170.12 | NP_055507.1 | |
SEC14L5 | XM_024450497.2 | c.464A>G | p.Asn155Ser | missense_variant | 5/16 | XP_024306265.1 | ||
SEC14L5 | XM_024450498.2 | c.464A>G | p.Asn155Ser | missense_variant | 5/16 | XP_024306266.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEC14L5 | ENST00000251170.12 | c.464A>G | p.Asn155Ser | missense_variant | 5/16 | 1 | NM_014692.2 | ENSP00000251170.6 | ||
SEC14L5 | ENST00000587469.1 | c.464A>G | p.Asn155Ser | missense_variant | 4/5 | 4 | ENSP00000468423.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000447 AC: 1AN: 223618Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 121274
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1447362Hom.: 0 Cov.: 31 AF XY: 0.00000973 AC XY: 7AN XY: 719110
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.464A>G (p.N155S) alteration is located in exon 5 (coding exon 4) of the SEC14L5 gene. This alteration results from a A to G substitution at nucleotide position 464, causing the asparagine (N) at amino acid position 155 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at